Eric M. Horwitz

2.2k total citations · 1 hit paper
41 papers, 1.6k citations indexed

About

Eric M. Horwitz is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eric M. Horwitz has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 23 papers in Radiation and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eric M. Horwitz's work include Advanced Radiotherapy Techniques (23 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Prostate Cancer Treatment and Research (17 papers). Eric M. Horwitz is often cited by papers focused on Advanced Radiotherapy Techniques (23 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Prostate Cancer Treatment and Research (17 papers). Eric M. Horwitz collaborates with scholars based in United States, United Kingdom and Canada. Eric M. Horwitz's co-authors include Nicholas G. Zaorsky, Brian L. Egleston, Joshua E. Meyer, T.M. Churilla, John A. Ridge, Susan G. Fisher, Alan Pollack, R Price, Mark K. Buyyounouski and Robert G. Uzzo and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Clinical Nutrition and Cancer.

In The Last Decade

Eric M. Horwitz

39 papers receiving 1.6k citations

Hit Papers

Causes of death among can... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Causes of death among cancer patients
    2016 450 citations Nicholas G. Zaorsky, T.M. Churilla et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric M. Horwitz United States 21 950 661 311 293 179 41 1.6k
Pranshu Mohindra United States 23 754 0.8× 458 0.7× 486 1.6× 398 1.4× 169 0.9× 128 1.5k
Robert T. Dess United States 20 1.0k 1.1× 361 0.5× 358 1.2× 412 1.4× 216 1.2× 102 1.6k
David Pryor Australia 20 757 0.8× 271 0.4× 382 1.2× 352 1.2× 385 2.2× 85 1.4k
Jesmin Shafiq Australia 17 523 0.6× 618 0.9× 827 2.7× 512 1.7× 263 1.5× 44 1.7k
Á. Montero Spain 17 317 0.3× 363 0.5× 346 1.1× 322 1.1× 262 1.5× 78 1.5k
Rolando Maria D’Angelillo Italy 22 1.1k 1.2× 406 0.6× 523 1.7× 464 1.6× 288 1.6× 112 1.8k
Sandra McDonald United States 15 755 0.8× 246 0.4× 739 2.4× 396 1.4× 216 1.2× 47 1.6k
Raymond B. Mailhot Vega United States 17 472 0.5× 275 0.4× 199 0.6× 143 0.5× 240 1.3× 102 988
Claes Mercke Sweden 23 742 0.8× 308 0.5× 188 0.6× 465 1.6× 382 2.1× 81 1.6k
Bhanu Prasad Venkatesulu United States 16 372 0.4× 175 0.3× 339 1.1× 535 1.8× 170 0.9× 53 1.2k

Countries citing papers authored by Eric M. Horwitz

Since Specialization
Citations

This map shows the geographic impact of Eric M. Horwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Horwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Horwitz more than expected).

Fields of papers citing papers by Eric M. Horwitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric M. Horwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Horwitz. The network helps show where Eric M. Horwitz may publish in the future.

Co-authorship network of co-authors of Eric M. Horwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Eric M. Horwitz. A scholar is included among the top collaborators of Eric M. Horwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric M. Horwitz. Eric M. Horwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyer, Joshua E., et al.. (2025). Experience and uncertainty analysis of CT-based adaptive radiotherapy for abdominal treatments. Physica Medica. 131. 104946–104946.
2.
Ghatalia, Pooja, Eric A. Ross, Matthew R. Zibelman, et al.. (2025). A phase 2 trial of risk enabled therapy after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer (RETAIN-2).. Journal of Clinical Oncology. 43(5_suppl). 815–815. 2 indexed citations
3.
Lukez, Alexander, Zhang Li, Eric M. Horwitz, et al.. (2025). Computed Tomography-Guided Online Adaptive Stereotactic Body Radiation Therapy for Liver Tumors: A Retrospective Study. International Journal of Radiation Oncology*Biology*Physics. 122(3). 659–667. 1 indexed citations
4.
Zaorsky, Nicholas G., Brian J. Davis, Paul L. Nguyen, et al.. (2017). The evolution of brachytherapy for prostate cancer. Nature Reviews Urology. 14(7). 415–439. 123 indexed citations
5.
Zaorsky, Nicholas G., T.M. Churilla, Brian L. Egleston, et al.. (2016). Causes of death among cancer patients. Annals of Oncology. 28(2). 400–407. 450 indexed citations breakdown →
6.
Zaorsky, Nicholas G., Thomas M. Churilla, Karen Ruth, et al.. (2016). Men’s health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer. American Journal of Clinical Nutrition. 104(6). 1583–1593. 2 indexed citations
7.
Zaorsky, Nicholas G., Talha Shaikh, Karen Ruth, et al.. (2016). Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy. Clinical Genitourinary Cancer. 15(2). 326–335.e3. 43 indexed citations
8.
Shaikh, Talha, Tianyu Li, Elizabeth A. Handorf, et al.. (2016). Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 97(4). 722–731. 34 indexed citations
9.
Ahmed, Awad A., Brian L. Egleston, Pino Alcántara, et al.. (2013). A Novel Method for Predicting Late Genitourinary Toxicity After Prostate Radiation Therapy and the Need for Age-Based Risk-Adapted Dose Constraints. International Journal of Radiation Oncology*Biology*Physics. 86(4). 709–715. 22 indexed citations
10.
Xue, Jiajia, Lili Chen, Mark K. Buyyounouski, et al.. (2013). CT-MRI Fusion Uncertainty in Prostate Treatment Planning for Different Image Guidance Techniques. International Journal of Radiation Oncology*Biology*Physics. 87(2). S718–S718. 5 indexed citations
11.
Lin, Mu‐Han, et al.. (2013). Reduction of prostate intrafractional motion from shortening the treatment time. Physics in Medicine and Biology. 58(14). 4921–4932. 25 indexed citations
12.
Ruth, Karen, Tahseen Al‐Saleem, Eric M. Horwitz, et al.. (2013). Gleason Scoring at a Comprehensive Cancer Center: What’s The Difference?. Journal of the National Comprehensive Cancer Network. 11(7). 812–819. 10 indexed citations
13.
Buyyounouski, Mark K., et al.. (2011). Potential Treatment Margin Reduction for Prostate Treatment with RapidArc and VMAT. International Journal of Radiation Oncology*Biology*Physics. 81(2). S391–S391. 1 indexed citations
14.
Pollack, Alan, Alexandra L. Hanlon, Eric M. Horwitz, et al.. (2005). Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. International Journal of Radiation Oncology*Biology*Physics. 64(2). 518–526. 197 indexed citations
15.
Buyyounouski, Mark K., Eric M. Horwitz, Robert G. Uzzo, et al.. (2004). The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 59(5). 1383–1391. 24 indexed citations
16.
Pollack, Alan, A.L. Hanlon, Eric M. Horwitz, et al.. (2003). Radiation therapy dose escalation for prostate cancer: a rationale for IMRT. World Journal of Urology. 21(4). 200–208. 65 indexed citations
17.
Price, R, Gerald E. Hanks, Shawn McNeeley, Eric M. Horwitz, & Wayne H. Pinover. (2002). Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery method. International Journal of Radiation Oncology*Biology*Physics. 53(1). 236–243. 20 indexed citations
18.
Hanlon, Alexandra L., Wayne H. Pinover, Eric M. Horwitz, & G. Hanks. (2001). Patterns and fate of PSA bouncing following 3D-CRT. International Journal of Radiation Oncology*Biology*Physics. 50(4). 845–849. 85 indexed citations
19.
Horwitz, Eric M., et al.. (1996). Pathologic and mammographic findings predicting the adequacy of tumor excision before breast-conserving therapy.. American Journal of Roentgenology. 167(6). 1409–1414. 33 indexed citations
20.
Horwitz, Eric M., Arthur Frazier, Richard D. Keidan, et al.. (1996). Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost. Cancer. 78(5). 948–957. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pranshu Mohindra Breakdown of academic impact, for papers by Robert T. Dess Breakdown of academic impact, for papers by David Pryor Breakdown of academic impact, for papers by Jesmin Shafiq Breakdown of academic impact, for papers by Á. Montero Breakdown of academic impact, for papers by Rolando Maria D’Angelillo Breakdown of academic impact, for papers by Sandra McDonald Breakdown of academic impact, for papers by Raymond B. Mailhot Vega Breakdown of academic impact, for papers by Claes Mercke Breakdown of academic impact, for papers by Bhanu Prasad Venkatesulu
Rankless by CCL
2026